January 27, 2022
European drug regulator backs mixing COVID-19 vaccines

European drug regulator backs mixing COVID-19 vaccines

The European Medicines Company mentioned in a press release that utilizing various kinds of vaccines collectively, referred to as heterologous vaccination, can present safety in opposition to COVID-19.

The announcement comes as a lot of Europe is dealing with rising an infection and hospital charges and considerations in regards to the new omicron variant.

The EMA, along with the European Middle for Illness Prevention and Management, mentioned {that a} mix-and-match technique may give nations extra choices in vaccination campaigns as a lot of the continent seeks to include the newest surge within the pandemic.

“The evidence available so far with different types of authorized vaccines indicates that a heterologous booster appears as good as or better in terms of immune responses than a homologous booster,” the companies mentioned in a press release.

“While research is ongoing to provide more evidence on long-term safety, duration of immunity and effectiveness, the use of heterologous schedules may offer flexibility in terms of vaccination options, particularly to reduce the impact on the vaccine rollout should a vaccine not be available for any reason,” they added.

The companies checked out information for mRNA vaccines just like the Pfizer shot and so-called viral vector vaccines such because the one made by Johnson & Johnson. The 2 kinds of vaccines use totally different applied sciences to spur the physique to battle the coronavirus.

U.S. and U.Okay. authorities have already given the inexperienced gentle to mixing and matching vaccines in booster campaigns.


Observe all AP tales on the pandemic at https://apnews.com/hub/coronavirus-pandemic.

Source link